Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05457907 · ClinicalTrials.gov registry record · NA
Ultrasound Therapy Effects to Modulate the Inflammatory Reflex
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05457907: Completed NA study, sponsored by Stanford University.
NCT05457907 is a NA study that has completed, run by Stanford University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05457907, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This two treatment group study, including sham treatment, attempts to measure how ultrasound frequency, duration, intensity, and duty cycle impact its acute anti-inflammatory effect in healthy volunteers. It also attempts to contribute to the evidence regarding the comfort and safety of using therapeutic ultrasound. This pilot dose-finding study will be the basis for a larger Phase 2 trial in Rheumatoid Arthritis (RA) patients.
Interventions
- DEVICE Ultrasound device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05457907
The ClinicalTrials.gov registry entry for NCT05457907 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound device is the first listed.
NCT05457907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05457907 about?
NCT05457907 is a clinical study titled "Ultrasound Therapy Effects to Modulate the Inflammatory Reflex". This two treatment group study, including sham treatment, attempts to measure how ultrasound frequency, duration, intensity, and duty cycle impact its acute anti-inflammatory effect in healthy volunteers. It also attempts to contribute to the evidence regarding the comfort and safety of using therap...
What is the current status of trial NCT05457907?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2023-01-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05457907?
The interventions under investigation include: Ultrasound device (DEVICE).
Who is sponsoring clinical trial NCT05457907?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.